Search Results - "Szklener, Sebastian"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope? by Szklener, Katarzyna, Szklener, Sebastian, Michalski, Adam, Żak, Klaudia, Kuryło, Weronika, Rejdak, Konrad, Mańdziuk, Sławomir

    Published in Nutrients (31-01-2022)
    “…Chemotherapy-induced peripheral neuropathy (CIPN) is one of the main and most prevalent side effects of chemotherapy, significantly affecting the quality of…”
    Get full text
    Journal Article
  2. 2

    Challenges for Service Robots-Requirements of Elderly Adults with Cognitive Impairments by Korchut, Agnieszka, Szklener, Sebastian, Abdelnour, Carla, Tantinya, Natalia, Hernández-Farigola, Joan, Ribes, Joan Carles, Skrobas, Urszula, Grabowska-Aleksandrowicz, Katarzyna, Szczęśniak-Stańczyk, Dorota, Rejdak, Konrad

    Published in Frontiers in neurology (01-06-2017)
    “…We focused on identifying the requirements and needs of people suffering from Alzheimer disease and early dementia stages with relation to robotic assistants…”
    Get full text
    Journal Article
  3. 3

    Systemic inflammatory response syndrome in the course of status epilepticus: 7-year, two-center observational study by Szklener, Sebastian, Korchut, Agnieszka, Godek, Magdalena, Balicka-Adamik, Luiza, Bielecki, Dariusz, Rejdak, Robert, Rejdak, Konrad

    Published in Epilepsy research (01-11-2017)
    “…•A systemic inflammatory response frequently coexists with status epilepticus, and therefore should be assessed routinely.•The assessment of SIRS among SE…”
    Get full text
    Journal Article
  4. 4

    Stereotactic radiosurgery in the treatment of essential tremor - a systematic review by Bilski, Mateusz, Szklener, Katarzyna, Szklener, Sebastian, Rudzińska, Anna, Kluz, Natalia, Klas, Jakub, Rodzajewska, Anna, Kuryło, Weronika, Korga, Mateusz, Baranowska, Izabela, Mańdziuk, Sławomir

    Published in Frontiers in neurology (03-04-2024)
    “…Essential tremor (ET) is the most common movement disorder in adults, with an estimated incidence of up to 1% of the population and 5% of people older than 65…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Long-Term Safety and Efficacy of Subcutaneous Cladribine Used in Increased Dosage in Patients with Relapsing Multiple Sclerosis: 20-Year Observational Study by Rejdak, Konrad, Zasybska, Adriana, Pietruczuk, Aleksandra, Baranowski, Dariusz, Szklener, Sebastian, Kaczmarek, Magda, Stelmasiak, Zbigniew

    Published in Journal of clinical medicine (08-11-2021)
    “…Cladribine is currently registered as a 10-milligram tablet formulation with a fixed cumulative dosage of 3.5 mg/kg over 2 years. It is important to…”
    Get full text
    Journal Article
  8. 8

    Outcome prediction in patients with acute repetitive seizures: Application of the Status Epilepticus Severity Score by Szklener, Sebastian, Godek, Magdalena, Korchut, Agnieszka, Balicka‐Adamik, Luiza, Rejdak, Robert, Rossetti, Andrea O., Rejdak, Konrad

    Published in Epilepsia (Copenhagen) (01-05-2018)
    “…Summary Acute repetitive seizures (ARS) pose a risk of hospital admission with status epilepticus and a mortality threat, which underscores the need for the…”
    Get full text
    Journal Article
  9. 9

    Predictive model for patients with poor-grade subarachnoid haemorrhage in 30-day observation: a 9-year cohort study by Szklener, Sebastian, Melges, Anna, Korchut, Agnieszka, Zaluska, Wojciech, Trojanowski, Tomasz, Rejdak, Robert, Rejdak, Konrad

    Published in BMJ open (12-06-2015)
    “…ObjectiveThe purpose of this study was to identify prognostic factors and build the predictive model based on poor-grade subarachnoid haemorrhage (SAH)…”
    Get full text
    Journal Article
  10. 10
  11. 11